Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Gauting – page 3

83 clinical trials in Gauting, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Gauting at a glance
83
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

83 trials in Gauting

Open in trial search
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:OSE Immunotherapeutics
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mrna-4157
  • Sponsor:Merck Sharp & Dohme LLC
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Infliximab
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Bi 764532
  • Sponsor:Boehringer Ingelheim International GmbH
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Immunitybio Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Igg-Like T Cell Engager Binding To Dll3 And Cd3
  • Sponsor:Technische Universitaet Dresden
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Treprostinil Palmitil
  • Sponsor:Insmed Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:AstraZeneca AB
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Oncoc4 Inc.
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Human Igg1 Kappa Monoclonal Antibody Against Crlf2
  • Sponsor:Upstream Bio Inc.

Other cities in Germany

The busiest research cities in the country

All 515 cities in Germany

Clinical research in Gauting

What the registry says about research in the country

01 Non-Small Cell Lung Cancer Research

Extensive clinical trials focusing on non-small cell lung cancer (NSCLC) treatments, including innovative combination therapies and targeted approaches for different disease stages.

  • Stage I adenocarcinoma treatments
  • Advanced and metastatic NSCLC therapies
  • Post-surgical adjuvant treatments

Multiple studies evaluating novel drug combinations and immunotherapy approaches for improving patient outcomes.

02 Small Cell Lung Cancer Studies

Research focusing on small cell lung cancer (SCLC), particularly examining new treatment options for extensive-stage disease and therapy-resistant cases.

  • Combination immunotherapy trials
  • Novel therapeutic agents
  • Treatment resistance strategies

Investigations into innovative treatment combinations and maintenance therapies for better disease management.

03 Specialized Lung Conditions

Studies addressing various specialized lung conditions, including pleural mesothelioma and rare pulmonary diseases.

  • Neuroendocrine tumors
  • Idiopathic pulmonary fibrosis
  • Nontuberculous mycobacterial infections

Clinical trials exploring targeted therapies and novel treatment approaches for rare and complex respiratory conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.